CVE-2023-49077

mailcow-dockerized XSS Vulnerability in Quarantine UI Allows Unauthorized Access and Data Manipulation

Description

Mailcow: dockerized is an open source groupware/email suite based on docker. A Cross-Site Scripting (XSS) vulnerability has been identified within the Quarantine UI of the system. This vulnerability poses a significant threat to administrators who utilize the Quarantine feature. An attacker can send a carefully crafted email containing malicious JavaScript code. This issue has been patched in version 2023-11.

Category

8.3
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.43%
Vendor Advisory github.com
Affected: mailcow mailcow-dockerized
Published at:
Updated at:

References

Link Tags
https://github.com/mailcow/mailcow-dockerized/security/advisories/GHSA-46x4-w2fm-5x6g vendor advisory
https://github.com/mailcow/mailcow-dockerized/releases/tag/2023-11 release notes

Frequently Asked Questions

What is the severity of CVE-2023-49077?
CVE-2023-49077 has been scored as a high severity vulnerability.
How to fix CVE-2023-49077?
To fix CVE-2023-49077, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-49077 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-49077 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-49077?
CVE-2023-49077 affects mailcow mailcow-dockerized.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.